|
Name |
Methyl 2-ethylhexanoate
|
Molecular Formula | C9H18O2 | |
IUPAC Name* |
methyl 2-ethylhexanoate
|
|
SMILES |
CCCCC(CC)C(=O)OC
|
|
InChI |
InChI=1S/C9H18O2/c1-4-6-7-8(5-2)9(10)11-3/h8H,4-7H2,1-3H3
|
|
InChIKey |
KICUISADAVMYCJ-UHFFFAOYSA-N
|
|
Synonyms |
Methyl 2-ethylhexanoate; 816-19-3; Hexanoic acid, 2-ethyl-, methyl ester; Hexanoic acid,2-ethyl-, methyl ester; 2-Ethylhexanoic Acid Methyl Ester; CHEMBL1762665; 2-Ethyl-methyl ester hexanoic acid; Methyl-2-Butyl-Butyrate; 3100891M19; EINECS 212-429-2; UNII-3100891M19; methyl 2 ethylhexanoate; AI3-33653; EC 212-429-2; SCHEMBL49923; 2-Ethylhexanoic acid methylester; DTXSID9052559; KICUISADAVMYCJ-UHFFFAOYSA-; BDBM50340083; Methyl ester of 2-ethylhexanoic acid; MFCD00043849; AKOS009513282; AS-76678; D93232; EN300-170600; Q27255986
|
|
CAS | 816-19-3 | |
PubChem CID | 102491 | |
ChEMBL ID | CHEMBL1762665 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 158.24 | ALogp: | 3.0 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 11 | QED Weighted: | 0.574 |
Caco-2 Permeability: | -4.299 | MDCK Permeability: | 0.00002750 |
Pgp-inhibitor: | 0.008 | Pgp-substrate: | 0.005 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.712 |
30% Bioavailability (F30%): | 0.909 |
Blood-Brain-Barrier Penetration (BBB): | 0.996 | Plasma Protein Binding (PPB): | 37.12% |
Volume Distribution (VD): | 1.081 | Fu: | 62.79% |
CYP1A2-inhibitor: | 0.915 | CYP1A2-substrate: | 0.923 |
CYP2C19-inhibitor: | 0.582 | CYP2C19-substrate: | 0.886 |
CYP2C9-inhibitor: | 0.238 | CYP2C9-substrate: | 0.578 |
CYP2D6-inhibitor: | 0.017 | CYP2D6-substrate: | 0.349 |
CYP3A4-inhibitor: | 0.081 | CYP3A4-substrate: | 0.315 |
Clearance (CL): | 8.568 | Half-life (T1/2): | 0.625 |
hERG Blockers: | 0.043 | Human Hepatotoxicity (H-HT): | 0.066 |
Drug-inuced Liver Injury (DILI): | 0.05 | AMES Toxicity: | 0.011 |
Rat Oral Acute Toxicity: | 0.052 | Maximum Recommended Daily Dose: | 0.027 |
Skin Sensitization: | 0.649 | Carcinogencity: | 0.133 |
Eye Corrosion: | 0.912 | Eye Irritation: | 0.974 |
Respiratory Toxicity: | 0.847 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000652 | 0.649 | D0Y3KG | 0.375 | ||||
ENC000306 | 0.618 | D0ZK8H | 0.289 | ||||
ENC002444 | 0.525 | D01QLH | 0.275 | ||||
ENC000211 | 0.488 | D07CNL | 0.269 | ||||
ENC000849 | 0.447 | D0X4FM | 0.253 | ||||
ENC000235 | 0.432 | D03LGY | 0.242 | ||||
ENC000570 | 0.422 | D0K3LW | 0.234 | ||||
ENC000212 | 0.422 | D0CT4D | 0.232 | ||||
ENC000726 | 0.415 | D02KBD | 0.228 | ||||
ENC000903 | 0.410 | D0ZI4H | 0.227 |